Prospective observational study of (177)Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

PURPOSE: Peptide receptor radionuclide therapy in patients with neuroendocrine tumours has yielded promising results. This prospective study investigated the feasibility of dosimetry of the kidneys and bone marrow during therapy and its impact on efficacy and outcome. METHODS: The study group compri...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Nucl Med Mol Imaging
Autori principali: Garske-Román, Ulrike, Sandström, Mattias, Fröss Baron, Katarzyna, Lundin, Lars, Hellman, Per, Welin, Staffan, Johansson, Silvia, Khan, Tanweera, Lundqvist, Hans, Eriksson, Barbro, Sundin, Anders, Granberg, Dan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915504/
https://ncbi.nlm.nih.gov/pubmed/29497803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-3945-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi